(Vax-Before-Travel News)
Spanish health authorities have informed the European Centre for Disease Prevention and Control (ECDC) of a confirmed case of human infection with the swine influenza A(H1N1)v virus.
This case was identified in February 2026 in the autonomous region of Catalonia. The patient remained completely asymptomatic, showing no flu-like symptoms such as fever, cough, or malaise, and has since made a full recovery.
Notably, the individual had no known history of exposure to pigs, pig farms, or contaminated environments, which distinguishes this case from most previous zoonotic infections. As of March 3, 2026, all identified close contacts tested negative, and there was no evidence of secondary transmission.
This marks the fourth human case of swine influenza A(H1N1)v reported in Spain over the past 17 years. Fortunately, there has never been documented human-to-human transmission of the A(H1N1) virus in Spain.
Catalonia, located in the northeast, is one of Spain’s most intensive pig-rearing regions and has recently faced separate challenges due to detections of African swine fever in wild boars in the Barcelona area.
The ECDC’s Communicable Disease Threats Report (Week 9, 2026) states, “Based on the information currently available, the likelihood of further transmission of variant A(H1N1) linked to this event is assessed to be very low.”
According to the latest available data from the U.S. CDC, there have been no confirmed cases of variant swine-origin influenza (A(H1N1)v, A(H1N2)v, or A(H3N2)v) reported for the ongoing 2025–26 flu season.
However, during the 2024–2025 flu season, one confirmed human case of swine-origin variant A(H1N2)v infection was reported in Iowa. The adult patient was hospitalized but made a full recovery.
According to the U.S. CDC, seasonal influenza vaccines for 2026 provide no direct protection against swine-origin variant virus strains seen in recent European cases, as those belong to different genetic lineages.